Check out the companies making headlines before the bell:Turning Point Therapeutics (TPTX) – The biopharmaceutical company's shares more than doubled in premarket trading after agreeing to be acquired by Bristol Myers Squibb (BMY)...
Hospital formulary entry stays to be the important thing focus for business uptake We expect the drug wouldn't have an excessive amount of bother stepping into hospital formularies contemplating the drug's sturdy...
